Your fact-checks will appear here
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
The Johnson & Johnson (Janssen) COVID‑19 vaccine has been linked to very rare, serious adverse events—primarily vaccine‑induced thrombosis with thrombocytopenia (VITT/TTS) and rare reports of Guillain...
Known long-term or delayed serious adverse events tied to the Johnson & Johnson (Janssen) COVID‑19 vaccine are rare and limited mainly to two clotting and neurologic syndromes — thrombosis with thromb...
Public, consumer-facing lot‑number lookup tools exist for some COVID‑19 vaccines (for example Moderna’s Vial Lookup and manufacturer/Janssen checkers), but Pfizer (Comirnaty/BNT162b2) does not maintai...
Pfizer and Moderna mRNA vaccines produce (injection-site pain, fatigue, headache, fever) that are generally mild and resolve in days, with likely due to a higher mRNA dose . Rare serious events differ...
The Johnson & Johnson (Janssen) COVID-19 vaccine has been linked to a very small number of rare but serious adverse events—most notably vaccine‑induced thrombotic thrombocytopenia (TTS, also called VI...
Available reporting shows large pharmaceutical companies and the industry trade group PhRMA gave sizable donations to Donald Trump’s 2025 inauguration committee — filings and press reports cite indivi...
Available reporting links Johnson & Johnson’s (J&J/Janssen) adenovirus‑vector COVID‑19 vaccine to a rare syndrome—thrombosis with thrombocytopenia syndrome (TTS)—with roughly 57–60 reported U.S. cases...
mRNA COVID-19 vaccines can trigger short-lived changes in immune markers and—in rare cases—cause inflammatory conditions such as myocarditis; major public-health reviews and cohort studies find no sus...
Regulatory agencies and multiple studies since 2021 have linked a very small number of neurological and immune-mediated conditions to the Janssen/Johnson & Johnson (J&J) adenoviral‑vector COVID‑19 vac...
Available reporting shows industrywide totals and past recipient lists but no single authoritative list in the provided sources naming “which senators receive the largest campaign donations from pharm...
Available reporting and official guidance do not describe the Janssen (Johnson & Johnson) COVID-19 vaccine as a substance the body “expels” on a defined timetable; rather, it is an intramuscular viral...
The evidence assembled shows that the Johnson & Johnson (Ad26.COV2.S) vaccine and mRNA vaccines (Pfizer-BioNTech, Moderna) have broadly favorable safety profiles but have been observed in post‑licensu...
Since 2021 monitoring and published summaries have linked the Johnson & Johnson (Janssen) COVID‑19 vaccine to a very small number of rare but serious events — most prominently thrombosis with thromboc...
Claims that authorities “lied” about COVID vaccines reflect a wider crisis of trust triggered by contested internal memos, political appointees reshaping public health messaging, and persistent online...
Available reporting shows the Trump family shifted from holding mostly diversified funds in 2021 to far broader and more concentrated public exposures by 2024–25, including hundreds of individual stoc...
Regulatory agencies and medical literature link the Johnson & Johnson/Janssen COVID-19 vaccine to a small but measurable increase in a few specific autoimmune-type disorders, most notably Guillain-Bar...
Reports and peer-reviewed reviews link several rare, long-term neurological syndromes to COVID-19 vaccination in general — most commonly Guillain-Barré syndrome (GBS), functional neurological disorder...
Bill Gates has made personal investments aimed at Alzheimer’s research totaling about $100 million — a $50 million check to the Dementia Discovery Fund (DDF) and roughly $50 million pledged for start‑...
Regulatory reviews and surveillance from 2021 onward identified a small number of rare but serious adverse events after the Janssen (Johnson & Johnson) COVID-19 vaccine — chiefly thrombosis with throm...
Available reporting and peer‑reviewed reviews show rare neurological events have been reported after COVID‑19 vaccination overall and some specific associations were identified with the Johnson & John...